COR Q4 2017 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$68B

Q4 2017 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$39.1B+4.2% YoY

Gross Profit

$1.1B2.7% margin

Operating Income

$507M1.3% margin

Net Income

-$295M-0.8% margin

EPS (Diluted)

$-1.35

QoQ Revenue Growth

+1.1%

Cash Flow

Operating Cash Flow

$1.4B

Free Cash Flow

$1.3B

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$35.3B

Total Liabilities

$33.3B

Stockholders' Equity

$2.1B

Cash & Equivalents

$2.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39.1B	$37.6B	+4.2%
Gross Profit	$1.1B	$1.0B	+3.7%
Operating Income	$507M	$500M	+1.4%
Net Income	-$295M	$144M	-305.1%

Revenue Segments

Pharmaceutical Distribution

$38.3B98%

Other Segments

$644M2%

Geographic Segments

Other Segments

$644M100%